See also this year's filing and all EDGAR filings for this company.
PDF Report 0001540159_2018_Edesa_Biotech_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 211849, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
Graph
Absolute values for 0001540159, Edesa Biotech Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 6,758,447 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 879,523 |
| 3 | remainder_Assets | 82,035 |
| 4 | LiabilitiesCurrent | 320,947 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 245,789 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,892,604 |
| 9 | ResearchAndDevelopmentExpense | 1,888,660 |
| 10 | remainder_Expenses | 295,286 |
| 11 | remainder_Revenues | 500,472 |
| 12 | remainder_NetIncome | 53,979 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 7,720,005 |
| 1 | Liabilities | 320,947 |
| 2 | Expenses | 5,322,339 |
| 3 | Revenues | 500,472 |
| 4 | StockholdersEquity | 7,399,058 |
| 5 | NetIncome | -4,767,888 |
| 6 | ComprehensiveNetIncome | -4,767,888 |
| 7 | BaseVar | 6,958,871 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.83 |
| 9 | EconomicCapitalRatio | 3.57 |